Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ProPhase Labs Inc (NASDAQ:PRPH)

1.29
Delayed Data
As of May 03
 -0.012 / -0.92%
Today’s Change
1.05
Today|||52-Week Range
1.75
-14.13%
Year-to-Date
No recent news for ProPhase Labs Inc.

Today’s Trading

Previous close1.30
Today’s open1.28
Day’s range1.28 - 1.29
Volume1,271
Average volume (3 months)8,191
Market cap$22.2M
Dividend yield--
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)+53.19%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.64%
P/E ratioNM
Price/Sales1.19
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
ENZNEnzon Pharmaceutical...+0.00+0.83%
SPHSSophiris Bio Inc+0.07+5.22%
VKTXViking Therapeutics ...+0.03+2.29%
WINTWindtree Therapeutic...-0.19-7.57%
Data as of 05/03/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$20.6M
Annual profit (last year)-$3.6M
Net profit margin-17.47%

Profile

Sector
Consumer Non-Durables
Industry
Household/Personal Care
Chairman, Chief Executive Officer &
IR Contact
Ted William Karkus
COO, CFO &
Principal Accounting Officer
Robert V. Cuddihy
Corporate headquarters
Doylestown, Pennsylvania

Forecasts

Partner Offers

Search for Jobs